The Stereochemical Challenge of Hidden Peptide Impurities: The Hidden Impurities in Peptides
Part II: The Hidden Impurities in Peptides
In Part 1 we discussed how stereochemical impurities may already exist within amino acid building blocks before peptide synthesis begins. Whether these impurities originate in the starting material or arise later through epimerization during peptide synthesis, they ultimately create the same analytical challenge. Once incorporated into the peptide, they become substantially more difficult to detect and characterize.
Why?
At first glance, this almost seems counterintuitive. If the amino acid can be analyzed before synthesis, why should analyzing that same stereochemical impurity become any more difficult once it’s incorporated into a peptide? The answer is that the analytical problem fundamentally changes. A peptide isn’t simply a collection of amino acids. It becomes an entirely new chemical entity, bringing with it a new level of analytical complexity.
Peptides Are Inherently More Complex Analytical Systems
Amino acids have always been some of the most challenging molecules for analytical chemists to work with. Their zwitterionic nature and diverse side-chain functionality have led to countless questions during method development. Which mobile phase additive should be used? At what concentration? What pH provides the best selectivity? What happens when multiple amino acids are present together? There is rarely a universal answer. Most of the time, the only solution is experimental determination1.
Couple those amino acids together into a peptide, however, and the analytical challenge changes completely. Not only does the peptide retain many of the analytical characteristics of its individual amino acid building blocks, it also begins to develop properties of its own. As peptide chains become longer, secondary and tertiary structure begin to influence chromatographic behavior1. Amino acids that are distant in the primary sequence may now exist in close three-dimensional proximity. Intramolecular hydrogen bonding, charge distribution, and molecular conformation all begin contributing to how that peptide behaves analytically.
This is what makes peptide stereochemistry so challenging. A stereochemical difference that may have been relatively straightforward to identify in an individual amino acid can become partially masked within the much more complex environment of a folded peptide.
The important point is that a peptide isn’t simply one large amino acid. Coupling together multiple amino acids isn’t an additive process. The resulting peptide is an entirely new chemical entity whose analytical behavior may be very different from anything predicted from the individual amino acids themselves.
Every Stereocenter Increases Complexity
We hinted at this in the previous section, but it deserves a closer look. Imagine a 20-residue peptide synthesized from amino acid building blocks that are all stereochemically pure. From a stereochemical standpoint, that is actually a relatively straightforward system. Ignoring the normal process-related impurities associated with peptide synthesis, the expectation is a single stereochemical product.
Now imagine that one amino acid building block contains equal amounts of its L- and D-forms. Assuming similar coupling efficiencies, the synthesis no longer produces a single peptide population. Instead, two peptide stereoisomers are generated, differing only in the stereochemistry of that one amino acid residue. Introduce another stereochemically impure building block, and the complexity increases again.
The important point isn’t the exact number of stereoisomers that may be generated in a real manufacturing process. Those depend on reaction kinetics, impurity levels, and the specific sequence being synthesized. Rather, the important point is that every additional source of stereochemical variability increases the analytical challenge. What begins as a relatively simple characterization problem can quickly become a mixture of closely related peptide stereoisomers that differ only in the configuration of one or more amino acid residues.
This is one of the reasons why identifying stereochemical impurities as early as possible in the manufacturing process is so valuable. The earlier the impurity is identified, the simpler the analytical problem generally becomes.
Why Short Peptides Matter
At this point, you may start wondering why we’re discussing dipeptides and tripeptides when many therapeutic peptides are twenty, thirty, or even more amino acids in length. Before you ask that, or stop reading altogether, the answer is that short peptides provide an ideal model system for understanding a much larger analytical challenge.
With fewer amino acids come fewer stereocenters, fewer intermolecular interactions, and less conformational complexity. That makes it easier to study stereochemical behavior while still preserving the analytical challenges associated with peptide chemistry.
Short peptides can also arise naturally during peptide development. They may be synthesized directly during process development, generated intentionally through peptide digestion for analytical characterization, or even serve as functional excipients in modern biopharmaceutical formulations2,3. Regardless of how they are produced, they represent analytically important molecules in their own right.
Peptide digestion, in particular, has become a valuable strategy for simplifying the characterization of larger peptide systems. Rather than attempting to analyze an intact therapeutic peptide, the molecule is enzymatically or chemically cleaved into smaller fragments that are generally easier to characterize. “Easier,” however, is a relative term.
Those fragments may still contain multiple stereogenic centers, and the digestion process itself must be carefully controlled to avoid introducing racemization that would alter the stereochemical composition of the resulting fragments.
For these reasons, short peptides provide an excellent analytical model for evaluating stereochemical selectivity before extending those same concepts to more complex peptide systems.
Conventional Methods Answer Different Questions
There are already a number of well-established analytical technologies available for peptide characterization, each developed to answer a specific question. None is inherently superior to another. In fact, they are complementary techniques, each providing a different piece of the overall analytical picture.
Mass spectrometry, for example, tells us molecular weight with extraordinary accuracy. That information is invaluable for confirming molecular identity, monitoring synthesis, and detecting many classes of impurities. But molecular weight alone does not define molecular identity. As we’ll discuss further in Part 3, two molecules can possess identical masses while differing significantly in their stereochemistry or even amino acid composition.
Reversed-phase HPLC (RP-HPLC) remains the workhorse separation technique for peptide analysis. Modern C18 and peptide-specific stationary phases routinely resolve highly complex mixtures and are indispensable for impurity profiling. However, these separations are driven primarily by hydrophobic interactions. While stereochemical changes may sometimes alter retention sufficiently to produce chromatographic separation, there is no guarantee they will do so. Peptides differing only in the configuration of a single stereocenter may still appear remarkably similar under conventional reversed-phase conditions.
Peptide mapping offers another powerful analytical strategy. Rather than attempting to characterize the intact peptide, enzymatic or chemical digestion produces smaller fragments that are generally easier to analyze. This approach has become an essential tool for confirming sequence integrity and investigating impurities. As discussed previously, however, the digestion process itself must preserve stereochemical integrity, and even relatively small peptide fragments may still contain sufficient stereochemical complexity to present significant analytical challenges.
Taken together, these techniques provide a remarkably complete analytical workflow, and they have earned their place as the foundation of modern peptide characterization. The question, however, is not whether these methods work. The question is whether they were designed to answer questions of stereochemistry.
A Different Analytical Approach
If stereochemistry represents a unique analytical challenge, perhaps it should be approached using a different separation mechanism. Most peptide analyses today rely on reversed-phase chromatography, where separation is driven largely by differences in hydrophobicity. While this approach is exceptionally versatile, stereochemical differences often produce only subtle changes in hydrophobic character, making separation of closely related stereoisomers difficult or inconsistent.
Ion-exchange chromatography offers an entirely different perspective. Peptides contain amino acids with neutral, acidic, and basic functionality, creating complex charge distributions that vary with sequence and structure. Rather than relying primarily on hydrophobic interactions, ion-exchange stationary phases exploit these differences in ionic character to generate selectivity. In doing so, they provide access to a separation space that conventional reversed-phase methods do not explore.
Detection presents another challenge. Many short peptides exhibit relatively weak native UV absorbance, limiting analytical sensitivity. Pre-column derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) addresses two important analytical needs simultaneously. First, it introduces a strong chromophore, greatly improving UV detectability. Second, it enhances stereochemical recognition when combined with an appropriate chiral stationary phase. Perhaps most importantly, the AQC derivatization protocol has been well established to preserve stereochemical integrity throughout the reaction, ensuring that the analytical result accurately reflects the stereochemical composition of the original sample4.
Using this approach, we evaluated two model peptide systems, a dipeptide and a tripeptide, each containing two stereogenic centers and therefore four expected stereoisomers5. In both cases, baseline separation of all stereoisomeric species was achieved following AQC derivatization, demonstrating that stereochemical complexity can be directly resolved even in peptide systems where conventional approaches often struggle.
The significance of this result extends beyond these individual model systems. It demonstrates that stereochemistry itself can become the basis for chromatographic selectivity, providing peptide scientists with another analytical dimension that complements, not replaces, the existing peptide characterization toolbox.
Looking Ahead
Throughout this article, we’ve discussed how stereochemical impurities become progressively more difficult to characterize once they are incorporated into a peptide. We’ve also shown that alternative chromatographic strategies can reveal differences that conventional analytical workflows may not always capture.
But peptide analysis presents another challenge that extends beyond stereochemistry alone. Some amino acids are structural isomers. Others are enantiomers. Some share identical molecular weights despite possessing entirely different chemical structures. As peptide complexity continues to increase, distinguishing between these closely related species becomes just as important as identifying stereochemical impurities themselves.
In Part 3, we’ll expand the discussion beyond peptide stereochemistry and examine one of the more subtle analytical blind spots in amino acid analysis: compounds that appear identical by mass, yet represent fundamentally different molecular structures. Understanding how to distinguish these species is another important step toward building a more complete analytical picture of peptide quality.
Citations
1Czerwenka, C.; Lindner, W. Stereoselective Peptide Analysis. Anal. Bioanal. Chem. 2005, 382, 599–638.
2R. Karongo, F. Li, F. Fiessinger, J. Horak, M. Lämmerhofer, 2025. Automated derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate for the enantioselective amino acid analysis of neurotensin synthesized by liquid-phase peptide synthesis, J. Pharm. Biomed. Anal. 263, 116916. https://doi.org/10.1016/j. jpba.2025.116916.
3C. Knappe, S.J. Jaag, T. Dema, R. Jaufmann, S. Buckenmaier, H. Gross, S. Grond, M. Lämmerhofer, Multicolumn two-dimensional liquid chromatography screening platform for stereopeptidomics and application to antimicrobial peptide polyene and lipopeptide, Anal. Chem. 97 (2025) 14048–14057. https://doi.org/10.1021/acs. analchem.5c02658.
4S.A. Cohen, Amino acid analysis using precolumn derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, Methods Mol. Biol. 159 (2000) 39–47. https://doi.org/10.1385/1-59259-047-0:039.
5Kinderstuth, L.; Alvarez, S.; Franco, P. Chiral Analysis of Short Peptides and Peptide Fragments with Vaast. Daicel Chiral Technologies Application Note, 2026
